Data de publicação: 05/03/2024 - 16:07
The Institute of Drug Technology (Farmanguinhos/Fiocruz) announced in 2/28 a partnership agreement with the Brazilian unit of the German pharmaceutical company Boehringer Ingelheim in Rio de Janeiro. This is the first step towards submitting and obtaining registration for a generic product of Jardiance®, empagliflozin 10 mg and 25 mg, with the Brazilian Health Regulatory Agency (Anvisa). The drug is indicated for the treatment of adults with...
Notícias
Data de publicação: 05/03/2024 - 15:43
Living on an extremely low income is a risk factor for a variety of health conditions, such as tuberculosis, malaria and AIDS. Previous studies have shown that public policies such as conditional cash transfer programs are among the most effective interventions for improving the well-being of individuals and families in low- and middle-income countries living in situations of vulnerability. A study published in the scientific journal Nature...
Notícias
Data de publicação: 11/04/2024 - 10:02
In front of representatives from 24 countries, Fiocruz opened on 4/3, and hosted until 4/5, the Second Global Workshop for countries presenting Voluntary National Reviews (VNRs), part of a series of three meetings organized by the United Nations to draw up proposals to be taken to the UN High-Level Political Forum on Sustainable Development (HLPF) in July. This is the first time the workshop has been held in Latin America, and its opening was...
Notícias
Data de publicação: 16/04/2024 - 14:30
Fiocruz Pernambuco has created a 100% national ingredient to be added to the rapid screening test for the diagnosis of visceral leishmaniasis (VL). The product can be used for both the human and canine populations, being the first with this dual efficacy. The product has already been assessed in laboratories and will soon be implemented in the field. VL is an infectious disease transmitted by the drain fly that can affect both humans and animals...
Notícias
Data de publicação: 16/04/2024 - 15:33
The Laboratory of Respiratory Viruses, Exanthematics, Enteroviruses and Viral Emergencies of the Oswaldo Cruz Institute (IOC/Fiocruz) is part of a new cooperation network of the World Health Organization (WHO) to monitor the different types of coronavirus. Called CoViNet, the initiative is an offshoot of the network of reference laboratories set up by WHO at the start of the public health emergency caused by Sars-CoV-2. The group brings together...
Notícias
Data de publicação: 29/02/2024 - 12:27
There are different parameters for assessing a child's development from birth, and weight and height gain is some of these factors. However, there are indirect influences that act on this factor of development. This is what a new study published by researchers from the Center for Data and Knowledge Integration for Health (Cidacs/Fiocruz Bahia) points out. The research findings suggest that the ethnicity/color of pregnant women affects the...
Notícias
Data de publicação: 29/02/2024 - 12:03
Fiocruz and the Federal University of Rio de Janeiro (UFRJ) signed an agreement last Wednesday (2/21) to set up a research center in the UFRJ Technology Park. The partnership between the institutions will allow setting up an innovation-promoting environment in the form of a health technology platform, aimed at developing products, services and technologies to meet the demands of the Unified Health System (SUS). Present at the signing ceremony...
Notícias
Data de publicação: 03/04/2024 - 16:03
The Institute of Technology on Immunobiologicals (Bio-Manguinhos/Fiocruz) and the pharmaceutical company Sanofi signed a Memorandum of Understanding last Wednesday (3/27) that reaffirms their mutual interest in establishing further collaborations in the field of immunization. In January this year, the institutions signed a technology transfer agreement for the domestic production of the acellular hexavalent vaccine. The immunizer offers...
Notícias
Data de publicação: 27/03/2024 - 14:05
The historic Fiocruz complex in Manguinhos, in Northern Rio de Janeiro, is a candidate for World Heritage status by the United Nations Educational, Scientific and Cultural Organization (UNESCO). The institution is now part of the tentative list of sites that can become Cultural, Natural and Mixed World Heritage Sites, a primary and obligatory stage for any property to begin the process of recognition.
Inscription of the historical complex...
Notícias
Data de publicação: 16/04/2024 - 15:12
Fiocruz hosted, from April 8th to 12th, the Fiocruz-Pasteur Network International Course on bioproduction, intellectual property and technology transfer. In the auditorium of the Rocha Lima Pavilion, on the Manguinhos Campus in Rio de Janeiro, 11 foreign students and 7 students from different units of the Foundation discussed topics such as research, development, production, quality control, clinical studies, regulatory issues and the...
Notícias
Data de publicação: 12/04/2024 - 11:02
During dengue epidemics, the resulting deaths, with rare exceptions, are avoidable. Dengue does not kill. What kills is the lack of care and attention to the signs of worsening that can appear, especially when the fever disappears. This neglected moment leads to avoidable serious cases and deaths.
Most of the avoidable deaths from dengue are the result of several errors, three of which stand out. The first is when patients or their families...
Notícias
Data de publicação: 26/02/2024 - 14:21
Since the beginning of the year, infections caused by the Aedes aegypt mosquito, such as dengue and chikungunya, have been on the rise. In recent weeks, Acre, Minas Gerais, Goiás and the Federal District have declared a state of emergency following an increase in the number of dengue cases, requiring extra care with the mosquito. Other cities are seeing the numbers rise not only for this disease, but also for chikungunya. The State of S...
Notícias
Data de publicação: 23/02/2024 - 15:01
The suicide rate among young people grew by 6% a year in Brazil between 2011 and 2022. In turn, notification rates for self-injuries in the 10-24 age group increased by 29% every year in the same period. The figure was higher compared to the general population, whose suicide rate grew by an average of 3.7% a year and self-injury by 21% a year over the same period. These results were found in the analysis of a set of nearly 1 million data points...
Notícias
Data de publicação: 11/04/2024 - 11:14
A survey of indigenous Yanomami people, from the Ninam subgroup, from nine villages located in Roraima, showed that all participants were contaminated by mercury. The highest levels of exposure were detected in indigenous people living in the villages closest to the illegal gold mines. The study Impact of Mercury on Protected Areas and Forest Peoples in the Amazon: An Integrated Health-Environment Approach was conducted by the Sergio Arouca...
Notícias
Data de publicação: 03/04/2024 - 14:29
Fiocruz, through the Institute of Drug Technology (Farmanguinhos/Fiocruz) and the René Rachou Institute (IRR/Fiocruz Minas), has signed a partnership agreement for research, development and innovation (RD&I) with the French pharmaceutical company Servier. The aim is to enable research into cancer treatments using natural samples. The event was attended by the presidents of France, Emmanuel Macron, and of Fiocruz, Mario Moreira....
Notícias
Data de publicação: 20/02/2024 - 15:57
The production of vaccines and diagnostic kits and the use of Wolbachia mosquitoes on a large scale were topics that led to the visit of the Nigerian and Indonesian Health ministers to Fiocruz on 2/8. With different agendas, they visited the Manguinhos Campus in Rio de Janeiro at different times and took part in meetings with members of the Foundation's units.
The similarities in health challenges between countries and the process of...
Notícias
Data de publicação: 26/03/2024 - 09:20
Fiocruz, a foundation from the Brazilian government's Ministry of Health, and Caring Cross, a 501(c)(3) non-profit dedicated to accelerating the development of advanced medicines and enabling access to advanced medicinal cures for all patients, everywhere, today announced a collaboration to develop local manufacturing of chimeric antigen receptor (CAR)-T cell and stem cell gene therapies for oncology, infectious, and genetic...
Notícias
Data de publicação: 20/02/2024 - 10:47
During the meeting of the 37th Summit of the African Union (AU), president Luiz Inácio Lula da Silva announced, last Saturday (17/2), the expansion of health cooperation with the continent, with the creation of a representation of Fiocruz in Addis Ababa, capital of Ethiopia. On the trip around the country, the president of the Foundation, Mario Moreira, accompanied the Brazilian delegation, representing Minister Nísia Trindade Lima...
Notícias
Data de publicação: 27/03/2024 - 11:25
With international partners, Fiocruz has launched a research project that aims to contribute to the health of populations and ecosystems in the Amazon and East Africa in the face of climate change and environmental degradation. The aim is to establish information systems to support local communities in border areas in assessing the impacts of environmental transformations on their well-being and in developing actions to prevent, adapt to and...
Notícias
Data de publicação: 26/03/2024 - 15:34
A survey carried out by Fiocruz/Unifase's Observatory of Children's Health (Observa Infância) reveals that dengue fever has hit children up to the age of 5 hardest in 2024. The analysis shows that adolescents between the ages of 10 and 14 have the highest number of cases recorded this year, while children under the age of 5 have the highest fatality rates, followed by those between the ages of 5 and 9. Observa Infância...
Notícias
Data de publicação: 20/02/2024 - 15:49
A delegation from the United Kingdom was at Fiocruz on February 5th for a meeting about The Global Health Network Latin America and the Caribbean (TGHN LAC). The consortium is supported by the Wellcome Trust and the following partners from Latin American and Caribbean countries: the Oswaldo Cruz Foundation, in Brazil; the Instituto de Efectividad Clínica y Sanitaria (IECS), in Argentina; the Instituto de Enfermedades Infecciosas y...
Notícias
Data de publicação: 19/02/2024 - 10:21
Fiocruz will be responsible for producing and delivering 600,000 dengue molecular diagnostic tests (RT-PCR) to the Ministry of Health (MS). The tests allow confirming the infection and identifying the circulating dengue serotype (1, 2, 3 and 4), but also Zika and chikungunya.
In addition to the 300,000 reactions to be delivered throughout the year, another 300,000 emergency tests will be offered in the first months of the year (photo:...
Notícias
Data de publicação: 01/04/2024 - 14:36
Last week, on a trip to China, Fiocruz was able to strengthen partnerships and prospect future cooperation in health technology and innovation, especially in the areas of vaccines, biologicals and advanced therapies. The Foundation's vice president for Health Production and Innovation, Marco Krieger, and the director of the Immunobiological Technology Institute (Bio-Manguinhos), Maurício Zuma, were in the Asian country to visit health...
Notícias
Data de publicação: 22/03/2024 - 16:38
The constant heat waves caused by climate change, combined with incomplete urbanization and the large circulation of people in certain areas, are influencing the spread of the dengue fever into the hinterlands of the country. This is revealed by the study Climate change, thermal anomalies, and the recent progression of dengue in Brazil, published on Nature's Scientific Reports portal. The text was written by researcher Christovam Barcellos,...
Notícias
Data de publicação: 09/02/2024 - 15:10
The Leônidas & Maria Deane Institute (ILMD/Fiocruz Amazônia), through the Surveillance Center for Emerging, Reemerging or Neglected Viruses, in partnership with several institutions, carried out the genomic and epidemiological characterization of the outbreak of the oropouche virus (Orov), which has been occurring since 2022. Orov is endemic to the Amazon region and has been recording outbreaks in Brazil since the 70s. Orov...
Notícias
O conteúdo deste portal pode ser utilizado para todos os fins não comerciais, respeitados e reservados os direitos morais dos autores.
